Home › Research › Topics › cognitive-impairment
cognitive-impairment
851 studies tagged cognitive-impairment, dated 1982-05-01 to 2026-09-16. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Feasibility of remote self-administered cognitive assessment in an Alzheimer's disease treatment clinic 2026-09-16
- Structural brain imaging for newly diagnosed cognitive impairment by Medicare coverage type 2026-09-15
- Detection and Continuous Monitoring of Memory Dysfunction in Mild Cognitive Impairment and Healthy Aging Through Adaptive Computational Phenotyping 2026-09-12
Studies
851 studies carry this tag.
Date range
1982 to 2026
Top journals
- Neurology 63
- Journal of Alzheimer's disease : JAD 31
- Archives of neurology 30
- Alzheimer s & Dementia 25
- Alzheimer's & dementia : the journal of the Alzheimer's Association 23
316 journals in all.
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Mild cognitive impairment (MCI) is a common condition in the elderly.
-
The occurrence of different and opposed response patterns after the same training indicates a risk in applying classical group statistics.
-
We have developed MCI risk scores using variables easily assessable in the clinical setting and that may be useful in routine patient care.
-
The Mini-Mental State Examination (MMSE) is the best-known and the most often used short screening tool for providing an overall measure of cognitive impairment in clinical, research and community settings.
-
Data sources EMBASE, CINAHL, MEDLINE, PsychInfo.
-
Our data indicate that the retinal nerve fiber layer degeneration is paralleled with dementia progression.
-
Diabetes increased the risk of conversion to dementia.
-
The National Institute of Neurological Disorders and Stroke-Canadian Stroke Network Vascular Cognitive Impairment Harmonization working group proposed a brief cognitive protocol for screening of vascular cognitive impairment.
-
Diabetes mellitus is associated with an increase in the risk of dementia and the proportion of patients who convert from mild cognitive impairment (MCI) to dementia.
-
Mild cognitive impairment in Parkinson's disease is an important predictor for the progression to PDD.
-
The advent of highly active antiretroviral therapy has prolonged the life expectancy of HIV patients and decreased the number of adults who progress to AIDS and HIV-associated dementia.
-
The current diagnosis process of dementia is resulting in a high percentage of cases with delayed detection.
-
56/100
The proportion of progressors was 11% (8/41), 34% (14/41), 56% (19/34), and 71% (60/85) in A-N-, A+N-, SNAP, and A+N+, respectively; the proportion of APOE ε4 carriers was 29%, 70%, 31%, and 71%, respectively, with the SNAP group featuring a significantly different proportion than both A+N- and A+N+ groups (p ≤ 0.005).
-
The delayed recall of auditory verbal learning test (AVLT_DR) identified 116 subjects as MCI, resulted in the conversion rate as 44% over the roughly 30-month time interval, missed 7.8% incipient Alzheimer's disease (AD) patients in SCD group who eventually converted to dementia.
-
The temporal relationship of cognitive deficit and functional impairment in Alzheimer's disease (AD) is not well characterized.
-
A number of studies have linked neuropsychiatric symptoms to increase risk of dementia.
-
Decline in olfactory activity was correlated with the AD structural degeneration in the POC.
-
All versions of the Montreal Cognitive Assessment (MoCA) lack population-based data of 80-plus individuals.
-
The identification of biological and pathophysiological processes implicated in different forms of dementia is itself dependent on reliable descriptions of cognitive performance and capacities.
-
The prevalence of MCI in adults aged 65 years and older is 10% to 20%; risk increases with age and men appear to be at higher risk than women.
-
Inexpensive, non-invasive tools for assessing Alzheimer-type pathophysiologies are needed.
-
The Montreal Cognitive Assessment (MoCA) is a rapid screening battery, also including subtests to assess frontal functions such as set-shifting, abstraction and cognitive flexibility.
-
Cognitive impairment is one of the earliest, most common, and most disabling non-motor symptoms in Parkinson's disease (PD).
-
Anxiety symptoms in aMCI predict conversion to AD, over and beyond the effects of depression, memory loss, or atrophy within AD neuroimaging biomarkers.
-
Chronic kidney disease (CKD) patients undergoing hemodialysis (HD) therapy have an increased risk of developing cognitive impairment and dementia, which are known relevant factors in disease prognosis and therapeutic success, but still lack adequate screening in clinical routine.
-
Mild cognitive impairment (MCI) increases dementia risk with no pharmacologic treatment available.
-
The 3D-CAM operationalizes the CAM algorithm using a 3-minute structured assessment with high sensitivity and specificity relative to a reference standard and could be an important tool for improving recognition of delirium.
-
Mild cognitive impairment and mild dementia are common problems in the elderly.
-
We developed and validated the Mini-Addenbrooke's Cognitive Examination (M-ACE) in dementia patients.
-
Cognitive impairment and memory dysfunction following stroke diagnosis are common symptoms that significantly affect the survivors' quality of life.
-
Guidelines recommend screening stroke-survivors for cognitive impairments.
-
Subjective cognitive complaints are a criterion for the diagnosis of mild cognitive impairment (MCI), despite their uncertain relationship to objective memory performance in MCI.
-
44/100
The Montreal Cognitive Assessment (MoCA) is a brief cognitive screening instrument developed by Nasreddine et al. to detect mild cognitive impairment, a high-risk condition for Alzheimer's disease and other forms of dementia.
-
Cognition clinic and memory clinic of a public hospital in Hong Kong.
-
Post-stroke cognitive impairment occurs frequently in the patients with stroke.
-
Mild cognitive impairment (MCI) as a precursor of dementia with Lewy bodies (DLB) is the focus of recent research, trying to explore the early mechanisms and possible biomarkers of DLB.
-
The Diagnostic Statistical Manual-5 (DSM-5) has included a category named the neurocognitive disorder which was formally known in DSM-IV as 'dementia, delirium, amnestic, and other cognitive disorders'.
-
Teleneuropsychology is proving to be an excellent resource for clarifying cognitive and psychiatric diagnoses, and integrating individual strengths, weaknesses, and preferences into treatment and care plans used by other health care providers, patients, and caregivers.
-
Four subtypes emerged: (1) dysnomic (n = 153), (2) dysexecutive (n = 102), (3) amnestic (n = 288), and (4) cluster-derived normal (n = 282) who performed within normal limits on cognitive testing.
-
Retinal nerve fiber layer thickness (RNFL) measured by means of Optical Coherence Tomography (OCT) has been used as a marker not only of ophthalmologic diseases but also of neurodegenerative diseases such as Alzheimer's disease (AD) and mild cognitive impairment (MCI).
-
A diagnosis of COPD is associated with an increased risk for MCI, particularly NA-MCI.
-
Among 2985 nondemented individuals, 601 were diagnosed with MCI, resulting in a prevalence of 20.1% for total MCI, 13.2% for amnestic MCI (aMCI), and 7.0% for non-amnestic MCI (naMCI).
-
The construct of mild cognitive impairment (MCI) has evolved over the past 10 years since the publication of the new MCI definition at the Key Symposium in 2003, but the core criteria have remained unchanged.
-
POCD can markedly impair postoperative recovery.
-
The prevalences of overall MCI, MCI-A, MCI-CVD, MCI-VRF, and MCI-O were 20.8% (95% confidence interval [CI] = 20.0-21.6%), 6.1% (95% CI = 5.7-6.6%), 3.8% (95% CI = 3.4-4.2%), 4.9% (95% CI = 4.5-5.4%), and 5.9% (95% CI = 5.5-6.4%) respectively.
-
Out of the 664 studies screened, five studies met eligibility criteria.
-
The speed and severity of clinical progression after Alzheimer disease (AD) diagnosis varies and depends on multiple factors, most not well elucidated.
-
Cognitive changes in normal individuals who will subsequently decline may be observed at least 6.5 years prior to symptom onset.
-
Depressive symptoms in MCI appear to be predictors for progression to AD.
-
50/100
Mild cognitive impairment (MCI) marks a transitional stage between healthy aging and dementia, but the understanding of MCI in the general population remains limited.
From across this tag
10 of the 850 studies in this tag, picked by a fixed rule (a hash of each study's address), not by score or date; each page of this list shows a different 10. The same 10 appear here every time.
- 6-Gingerol attenuates LPS-induced neuroinflammation and cognitive impairment partially via suppressing astrocyte overactivation
- Inflammatory markers in type 2 diabetes with vs. without cognitive impairment; a systematic review and meta-analysis
- Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: the need for rigor
- Oral diadochokinesis performance correlates with mild cognitive impairment: a cross-sectional study
- Post-discharge Follow-up of Standardized Management for Patients with Post-stroke Cognitive Impairment
- Cognitive impairment associated with atrial fibrillation: a meta-analysis
- Acute Kidney Injury, Mild Cognitive Impairment, and Dementia: A Cohort Study of Patients from SPRINT
- Late-life depression, mild cognitive impairment, and dementia: possible continuum?
- The Validity and Reliability of the Mini-Mental State Examination-2 for Detecting Vascular Mild Cognitive Impairment and Vascular Dementia in a Korean Population
- Predictors of progression from mild cognitive impairment to Alzheimer disease